Home

Vivo Ventures Fund V, L.P.

CIK 1398937 · last filed 2019-12-03

Vivo Ventures Fund V, L.P. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing shows the insider sold $165.4K of SLNO on Dec 3, 2019. Across all open-market trades the lifetime net is −$29.1M, making them a net seller over the disclosed history. The firm reports its address in Palo Alto, CA. 29 SEC filings were submitted jointly with Vivo Ventures V Affiliates Fund, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

9

Lifetime Open-Market Net

-$29.07M

Filer Profile

Reported Address
505 HAMILTON AVENUE, SUITE 200
PALO ALTO, CA 94301
Phone
(650) 688-0818
State of Incorporation
DE
Related Filers
Vivo Ventures V Affiliates Fund, L.P. — 29 joint filings, latest 2019-12-03
Vivo Ventures V, LLC — 29 joint filings, latest 2019-12-03
BIOASIA MANGEMENT LLC — 2 joint filings, latest 2014-11-20
BIOTECHNOLOGY DEVELOPMENT FUND II LP — 2 joint filings, latest 2014-11-20
Biotechnology Development Fund IV Affiliates LP — 2 joint filings, latest 2014-11-20
Albert Cha — 2 joint filings, latest 2014-11-20
EDGAR ENGLEMAN — 2 joint filings, latest 2014-11-20
Frank Kung — 2 joint filings, latest 2014-11-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SOLENO THERAPEUTICS INC (SLNO) Delisted 10%+ Owner 242,254 $53.01 $12.84M -$249.2K 2 2019-12-03
SOLENO THERAPEUTICS INC (SLNOW) Delisted 10%+ Owner 3,886,226 — — -$40.8K 1 2019-11-07
SOLENO THERAPEUTICS INC (CAPN.W) Delisted 10%+ Owner 79,653 — — $0 3 2016-01-12
Sagent Pharmaceuticals, Inc. (SGNT) Delisted 10%+ Owner 3,496,951 — — -$28.45M 1 2015-11-04
Lite Strategy, Inc. (MEIP) Delisted 10%+ Owner 11,561 $3.20 $37.0K -$330.9K 2 2013-07-02

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-12-03 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −102,084 -$165.4K EDGAR
2019-11-27 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −54,207 -$83.8K EDGAR
2019-11-07 SOLENO THERAPEUTICS INC (SLNOW) Delisted Sell (S) −26,292 -$40.8K EDGAR
2016-01-12 SOLENO THERAPEUTICS INC (CAPN.W) Delisted Other (J) +1,001,361 $0 EDGAR
2015-11-23 SOLENO THERAPEUTICS INC (CAPN.W) Delisted Other (J) +4,929,927 $0 EDGAR
2015-11-04 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −1,809,531 -$28.45M EDGAR
2015-08-18 SOLENO THERAPEUTICS INC (CAPN.W) Delisted Other (J) +3,153,762 $0 EDGAR
2013-07-02 Lite Strategy, Inc. (MEIP) Delisted Sell (S) −1,278 -$9.7K EDGAR
2013-06-13 Lite Strategy, Inc. (MEIP) Delisted Sell (S) −41,181 -$321.2K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.